Tag: Pharmaceutical Industry

Bernie Sanders said Tuesday he would unveil a bill that introduces a series of reforms for combating high drug prices. (AP Photo)Â

Sanders pursues reforms to combat high drug prices

Robert King · September 1, 2015 3:49 pm

Research technicians prepare DNA samples in the production lab of the New York Genome Center. The relatively low cost of genomic sequencing is one reason personalized medicine seems promising. (Getty File Photo)

Old drugs may bring new life to cancer patients

Robert King · September 1, 2015 4:01 am

Rep. Elijah Cummings of Maryland wrote to Warner West Pharmacy and CVS Health Monday demanding answers to news reports that Warner West submitted the expensive claim for the supplement Reservatrol. (AP Photo)

Dem investigates $44,000 prescription

Robert King · August 31, 2015 6:25 pm

Pictured above is Roche Holding AG's Tarceva cancer drug.Â A new study examined the value of a cancer drug up for approval and found that its price should be linked to the effectiveness of the product.Â (JB Reed/Bloomberg)

Are value studies the cure for high drug prices?

Robert King · August 30, 2015 4:01 am

The Food and Drug Administration approved Repatha Thursday, for two groups of patients who are unable to control their cholesterol with existing drugs and treatments. (Amgen Inc. via AP)

FDA approves another game-changing cholesterol drug

Robert King · August 28, 2015 1:52 pm

A medical worker shows capsules as he works at the Middle East Company for Pharmaceutical Industries September 08, 2008 in Bait Hanoun, Gaza Strip. (Photo by Abid Katib/Getty Images)

New international trade deal must include robust drug rights

Andrew Langer · August 27, 2015 4:01 am

In July, the FDA announced it intends to require four types of quality metrics fromÂ pharmaceuticalÂ manufacturers and three optional ones. It held a meeting to get industry feedback on the metrics on Monday.Â (AP Photo/Gregory Bull)

Government wants to grade drugmakers, but keep grades secret

Robert King · August 25, 2015 4:01 am

In this Friday, Sept. 27, 2013, photo, Cindy Whitehead holds a tablet of flibanserin in her office at Sprout Pharmaceuticals in Raleigh, N.C. The daily pill is designed to increase libido in women by acting on brain chemicals linked to mood and appetite. (AP Photo/Allen G. Breed)

OK for female sex drug follows patient-centered trend

Robert King · August 23, 2015 4:01 am

In 2009, the manufacturer of Zicam voluntarily recalled nasal products using zinc in the drug after consumers claimed they lost their ability to smell. (Getty)

Overhaul of rules for homeopathic drugs wanted

Robert King · August 21, 2015 8:44 pm

A tablet of flibanserin sits on a brochure for Sprout Pharmaceuticals.Â Valeant Pharmaceuticals will acquire Sprout Pharmaceuticals for about $1 billion.Â (AP Photo/Allen G. Breed)

Female libido drug maker to be sold

Robert King · August 20, 2015 12:14 pm

Obamacare supporters and protesters gather in front of the U.S. Supreme Court to find out the ruling on the Affordable Health Act June 28, 2012 in front of the U.S. Supreme Court in Washington, D.C. (Photo by Alex Wong/Getty Images)

Poll: Americans split on Obamacare but agreed on prescription drug policies

Paige Winfield Cunningham · August 20, 2015 7:00 am

Sprout Pharmaceuticals CEO Cindy Whitehead holds a bottle for the female sex-drive drug Addyi. After two rejections, the U.S. Food and Drug Administration gave approval Tuesday for the drug as a treatment for hypoactive sexual desire disorder, a first for women. (AP Photo/Allen G. Breed)

Female libido drug won’t be marketed on TV

Robert King · August 19, 2015 3:11 pm